Efficacy Evidence Opens Door To Sell More Doctors On Joint Health Supplements
This article was originally published in The Tan Sheet
Executive Summary
Some doctors need more than impressive study results to change their routines, says Nicholas DiNubile, an orthopedic surgeon and a proponent of chondroitin/glucosamine supplementation for osteoarthritis patients. The patients, he says, often are asking about options to treatment with NSAIDs.
You may also be interested in...
Study Makes MOVES For Chondroitin/Glucosamine On Osteoarthritis Pain
At six months, 79.7% of the moderate-to-severe patients in the supplementation group and 79.2% in the celecoxib group fulfilled pain reduction criteria, the primary outcome measured in the Multicenter Osteoarthritis InterVEntion trial with SYSADOA.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.